Highlight
Summary
About the Role
About You
- Ph.D. with 5-10 years of industry experience, or BS/MS with 10+ years of experience in biopharmaceutical development, with an emphasis on preclinical safety.
- Experience running GLP Toxicology studies.
- Previous experience with biologics and monoclonal antibodies.
- Strong knowledge of FDA, EMA, and ICH guidance documents including GLP regulations.
Benefits
- A 401(k) retirement plan with a 10% dollar-for-dollar match.
- Medical, dental and vision benefits, with Visterra contributing 85% to the monthly premium.
- A rich mental & behavioral wellness program.
- Short- and long-term disability programs.
- Group and voluntary life insurance.
- Pre-tax flexible spending and commuter accounts.
- 17 days of personal time, discretionary sick time, and 11 holidays per calendar year.
- Twelve weeks of paid parental leave for birth or adoption.
- A broad fitness reimbursement program.
- Tuition and student loan reimbursement.
Visterra is a clinical stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases. Our proprietary technology platform enables the design and engineering of precision antibody-based product candidates that specifically bind to, and modulate, key disease targets. Applying this technology to disease targets that are not adequately addressed by traditional therapeutic approaches, we are developing a robust pipeline of novel therapies for patients with unmet needs. Our most advanced program is in Phase 2 clinical development. In addition, Visterra has established a number of partnerships to progress novel antibodies engineered to treat significant diseases with limited treatment options.